2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Lymphangiomyoma: new trials by email Literature Review of Lymphangiomyoma trials Research Report on Lymphangiomyoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex. Everolimus - Renal Angiomyolipoma | Phase 4 | Completed | Novartis Pharmaceuticals | 40 | 2018-11-09 | 2021-09-09 |
| Doxycycline In Lymphangioleiomyomatosis (LAM) Doxycycline, Placebo - Lymphangioleiomyomatosis, Tuberous Sclerosis | Phase 4 | Completed | University of Nottingham | 24 | 2009-07-01 | 2015-12-02 |
Lymphangioleiomyomatosis (2) · Tuberous Sclerosis (2) · Angiomyolipoma (1)
Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Hamartoma (2) · Hemic and Lymphatic Diseases (2) · Heredodegenerative Disorders, Nervous System (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Malformations of Cortical Development (2) · Malformations of Cortical Development, Group I (2) · Neoplasm, Lymphatic Tissue (2) · Neoplasms (2)
Doxycycline (1) · Everolimus (1)
Novartis Pharmaceuticals (1) · University of Nottingham (1)
China (1) · United Kingdom (1)